Share Price and Basic Stock Data
Last Updated: July 26, 2025, 1:41 pm
| PEG Ratio | 0.00 |
|---|
Quick Insight
Wockhardt Ltd, currently priced at ₹1,678, presents a mixed financial profile within the pharmaceuticals sector, indicated by a market capitalization of ₹27,257 crore. The company's return on equity (ROE) stands at a modest 1.22%, while return on capital employed (ROCE) is slightly better at 3.75%, suggesting inefficiencies in generating profits relative to equity and capital. With a net profit margin of -57%, the firm faces significant profitability challenges. However, the promoter holding at 49.09% and a reasonable interest coverage ratio (ICR) of 1.79x indicate a degree of confidence from major stakeholders. Given the high price-to-book value ratio of 5.30x, investors should approach Wockhardt with caution, focusing on its operational turnaround potential before committing further capital.
Competitors of Wockhardt Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 140 Cr. | 99.0 | 247/84.3 | 27.0 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
| MPS Pharmaa Ltd | 4.95 Cr. | 2.59 | 4.33/2.50 | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 35.8 Cr. | 48.2 | 94.9/45.2 | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 34.2 Cr. | 23.3 | 29.1/13.1 | 33.5 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 19,293.10 Cr | 1,213.40 | 56.55 | 193.83 | 0.31% | 16.63% | 15.26% | 6.18 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 655 | 595 | 679 | 699 | 678 | 644 | 753 | 701 | 700 | 739 | 809 | 721 | 743 |
| Expenses | 688 | 611 | 636 | 654 | 675 | 628 | 681 | 664 | 759 | 648 | 699 | 593 | 679 |
| Operating Profit | -33 | -16 | 43 | 45 | 3 | 16 | 72 | 37 | -59 | 91 | 110 | 128 | 64 |
| OPM % | -5% | -3% | 6% | 6% | 0% | 2% | 10% | 5% | -8% | 12% | 14% | 18% | 9% |
| Other Income | -169 | 57 | -138 | -1 | -64 | 0 | 24 | 8 | 10 | 30 | 9 | 8 | 15 |
| Interest | 86 | 73 | 70 | 83 | 76 | 79 | 76 | 77 | 73 | 73 | 73 | 60 | 48 |
| Depreciation | 59 | 64 | 65 | 66 | 56 | 55 | 55 | 55 | 58 | 54 | 55 | 55 | 53 |
| Profit before tax | -347 | -96 | -230 | -105 | -193 | -118 | -35 | -87 | -180 | -6 | -9 | 21 | -22 |
| Tax % | -10% | -22% | -10% | -3% | 23% | 15% | 109% | -1% | -2% | 167% | 78% | 5% | 105% |
| Net Profit | -311 | -75 | -207 | -102 | -237 | -136 | -73 | -86 | -177 | -16 | -16 | 20 | -45 |
| EPS in Rs | -17.91 | -4.65 | -13.12 | -6.66 | -14.44 | -9.30 | -5.34 | -5.76 | -11.02 | -0.91 | -1.43 | 0.86 | -1.54 |
Last Updated: May 31, 2025, 7:17 am
Below is a detailed analysis of the quarterly data for Wockhardt Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 743.00 Cr.. The value appears strong and on an upward trend. It has increased from 721.00 Cr. (Dec 2024) to 743.00 Cr., marking an increase of 22.00 Cr..
- For Expenses, as of Mar 2025, the value is 679.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 593.00 Cr. (Dec 2024) to 679.00 Cr., marking an increase of 86.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 64.00 Cr.. The value appears to be declining and may need further review. It has decreased from 128.00 Cr. (Dec 2024) to 64.00 Cr., marking a decrease of 64.00 Cr..
- For OPM %, as of Mar 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Dec 2024) to 9.00%, marking a decrease of 9.00%.
- For Other Income, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 7.00 Cr..
- For Interest, as of Mar 2025, the value is 48.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 60.00 Cr. (Dec 2024) to 48.00 Cr., marking a decrease of 12.00 Cr..
- For Depreciation, as of Mar 2025, the value is 53.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 55.00 Cr. (Dec 2024) to 53.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Mar 2025, the value is -22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Dec 2024) to -22.00 Cr., marking a decrease of 43.00 Cr..
- For Tax %, as of Mar 2025, the value is 105.00%. The value appears to be increasing, which may not be favorable. It has increased from 5.00% (Dec 2024) to 105.00%, marking an increase of 100.00%.
- For Net Profit, as of Mar 2025, the value is -45.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Dec 2024) to -45.00 Cr., marking a decrease of 65.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is -1.54. The value appears to be declining and may need further review. It has decreased from 0.86 (Dec 2024) to -1.54, marking a decrease of 2.40.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 3:24 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,830 | 4,482 | 4,453 | 4,015 | 3,937 | 3,566 | 2,844 | 2,708 | 3,230 | 2,651 | 2,798 | 3,012 |
| Expenses | 3,805 | 3,772 | 3,959 | 4,002 | 3,935 | 3,604 | 2,725 | 2,771 | 2,932 | 2,549 | 2,707 | 2,619 |
| Operating Profit | 1,026 | 709 | 494 | 13 | 2 | -38 | 119 | -63 | 298 | 102 | 91 | 393 |
| OPM % | 21% | 16% | 11% | 0% | 0% | -1% | 4% | -2% | 9% | 4% | 3% | 13% |
| Other Income | 88 | 67 | 66 | 114 | -238 | 116 | 133 | 975 | -163 | -173 | 17 | 62 |
| Interest | 83 | 55 | 129 | 225 | 255 | 265 | 276 | 249 | 299 | 302 | 305 | 254 |
| Depreciation | 140 | 145 | 142 | 149 | 150 | 164 | 224 | 246 | 247 | 251 | 223 | 217 |
| Profit before tax | 891 | 575 | 289 | -247 | -641 | -351 | -247 | 417 | -411 | -624 | -420 | -16 |
| Tax % | 5% | 28% | 13% | -9% | 4% | -38% | -82% | -65% | -32% | -0% | 12% | 256% |
| Net Profit | 843 | 413 | 252 | -226 | -667 | -217 | -43 | 688 | -279 | -621 | -472 | -57 |
| EPS in Rs | 58.91 | 28.30 | 17.45 | -13.62 | -42.30 | -13.52 | -4.81 | 47.64 | -16.94 | -38.80 | -30.18 | -2.89 |
| Dividend Payout % | 13% | 54% | 0% | -56% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -51.01% | -38.98% | -189.68% | -195.13% | 67.47% | 80.18% | 1700.00% | -140.55% | -122.58% | 23.99% | 87.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | 12.03% | -150.70% | -5.45% | 262.60% | 12.72% | 1619.82% | -1840.55% | 17.97% | 146.57% | 63.93% |
Wockhardt Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | 15% |
| TTM: | 88% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 48% |
| 3 Years: | 98% |
| 1 Year: | 97% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 0% |
| 3 Years: | -7% |
| Last Year: | -1% |
Last Updated: Unknown
Balance Sheet
Last Updated: July 25, 2025, 2:03 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 72 | 72 | 77 | 81 |
| Reserves | 3,228 | 3,362 | 3,720 | 3,281 | 2,797 | 2,619 | 2,616 | 3,321 | 3,777 | 3,282 | 3,282 | 4,272 |
| Borrowings | 2,205 | 2,309 | 2,677 | 4,160 | 3,748 | 3,375 | 3,582 | 2,674 | 2,198 | 2,184 | 2,356 | 2,021 |
| Other Liabilities | 1,134 | 1,213 | 1,622 | 1,486 | 1,528 | 1,764 | 1,894 | 1,696 | 2,168 | 2,113 | 1,899 | 1,726 |
| Total Liabilities | 6,622 | 6,939 | 8,074 | 8,982 | 8,128 | 7,813 | 8,148 | 7,746 | 8,215 | 7,651 | 7,614 | 8,100 |
| Fixed Assets | 2,295 | 2,123 | 2,809 | 2,773 | 2,888 | 3,058 | 3,502 | 3,343 | 3,462 | 3,042 | 2,881 | 2,736 |
| CWIP | 708 | 1,007 | 1,036 | 1,244 | 1,433 | 1,445 | 1,585 | 1,379 | 1,342 | 1,539 | 1,722 | 2,033 |
| Investments | 577 | 341 | 0 | 563 | 214 | 0 | 0 | 0 | 0 | 0 | 0 | 422 |
| Other Assets | 3,043 | 3,468 | 4,228 | 4,403 | 3,593 | 3,309 | 3,060 | 3,024 | 3,411 | 3,070 | 3,011 | 2,909 |
| Total Assets | 6,622 | 6,939 | 8,074 | 8,982 | 8,128 | 7,813 | 8,148 | 7,746 | 8,215 | 7,651 | 7,614 | 8,100 |
Below is a detailed analysis of the balance sheet data for Wockhardt Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 4.00 Cr..
- For Reserves, as of Mar 2025, the value is 4,272.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,282.00 Cr. (Mar 2024) to 4,272.00 Cr., marking an increase of 990.00 Cr..
- For Borrowings, as of Mar 2025, the value is 2,021.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,356.00 Cr. (Mar 2024) to 2,021.00 Cr., marking a decrease of 335.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,726.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,899.00 Cr. (Mar 2024) to 1,726.00 Cr., marking a decrease of 173.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 8,100.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,614.00 Cr. (Mar 2024) to 8,100.00 Cr., marking an increase of 486.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2,736.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,881.00 Cr. (Mar 2024) to 2,736.00 Cr., marking a decrease of 145.00 Cr..
- For CWIP, as of Mar 2025, the value is 2,033.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,722.00 Cr. (Mar 2024) to 2,033.00 Cr., marking an increase of 311.00 Cr..
- For Investments, as of Mar 2025, the value is 422.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 422.00 Cr., marking an increase of 422.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,909.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,011.00 Cr. (Mar 2024) to 2,909.00 Cr., marking a decrease of 102.00 Cr..
- For Total Assets, as of Mar 2025, the value is 8,100.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,614.00 Cr. (Mar 2024) to 8,100.00 Cr., marking an increase of 486.00 Cr..
Notably, the Reserves (4,272.00 Cr.) exceed the Borrowings (2,021.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.00 | 707.00 | 492.00 | 9.00 | -1.00 | -41.00 | 116.00 | -65.00 | 296.00 | 100.00 | 89.00 | 391.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 36 | 60 | 91 | 94 | 89 | 130 | 159 | 124 | 104 | 110 | 81 |
| Inventory Days | 221 | 201 | 250 | 249 | 243 | 174 | 183 | 209 | 256 | 222 | 216 | 201 |
| Days Payable | 132 | 113 | 136 | 144 | 117 | 122 | 187 | 272 | 223 | 265 | 285 | 240 |
| Cash Conversion Cycle | 151 | 124 | 175 | 196 | 220 | 141 | 126 | 97 | 157 | 60 | 41 | 41 |
| Working Capital Days | 42 | 9 | 43 | 97 | 96 | -16 | 7 | -47 | 122 | 62 | 53 | 21 |
| ROCE % | 42% | 18% | 10% | 7% | -1% | -1% | -1% | 0% | 12% | 1% | -0% | -1% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal S&P BSE Healthcare ETF | 642 | 0.29 | 0.03 | 642 | 2025-04-22 17:25:15 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -3.02 | -32.05 | -38.79 | -20.24 | 61.95 |
| Diluted EPS (Rs.) | -3.02 | -32.05 | -38.79 | -20.24 | 61.68 |
| Cash EPS (Rs.) | 9.88 | -16.17 | -25.69 | -2.22 | 84.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 268.70 | 237.79 | 254.31 | 291.81 | 339.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 268.70 | 237.79 | 254.31 | 291.81 | 339.43 |
| Revenue From Operations / Share (Rs.) | 185.93 | 181.69 | 184.10 | 224.31 | 244.48 |
| PBDIT / Share (Rs.) | 28.09 | 7.92 | 15.49 | 22.08 | 6.25 |
| PBIT / Share (Rs.) | 14.69 | -6.56 | -1.94 | 4.93 | -15.96 |
| PBT / Share (Rs.) | -0.98 | -27.27 | -43.33 | -28.54 | 81.42 |
| Net Profit / Share (Rs.) | -3.52 | -30.65 | -43.13 | -19.38 | 62.16 |
| NP After MI And SOA / Share (Rs.) | -2.90 | -30.06 | -38.82 | -16.94 | 61.93 |
| PBDIT Margin (%) | 15.10 | 4.36 | 8.41 | 9.84 | 2.55 |
| PBIT Margin (%) | 7.90 | -3.60 | -1.05 | 2.19 | -6.52 |
| PBT Margin (%) | -0.53 | -15.01 | -23.53 | -12.72 | 33.30 |
| Net Profit Margin (%) | -1.89 | -16.86 | -23.42 | -8.63 | 25.42 |
| NP After MI And SOA Margin (%) | -1.56 | -16.54 | -21.08 | -7.55 | 25.33 |
| Return on Networth / Equity (%) | -1.07 | -13.78 | -16.66 | -6.33 | 20.31 |
| Return on Capital Employeed (%) | 3.90 | -2.07 | -0.65 | 1.40 | -3.79 |
| Return On Assets (%) | -0.57 | -6.05 | -7.27 | -2.96 | 8.82 |
| Long Term Debt / Equity (X) | 0.27 | 0.26 | 0.06 | 0.09 | 0.14 |
| Total Debt / Equity (X) | 0.42 | 0.62 | 0.56 | 0.48 | 0.46 |
| Asset Turnover Ratio (%) | 0.38 | 0.36 | 0.33 | 0.20 | 0.15 |
| Current Ratio (X) | 1.26 | 0.78 | 0.64 | 0.80 | 0.77 |
| Quick Ratio (X) | 0.90 | 0.55 | 0.45 | 0.56 | 0.52 |
| Inventory Turnover Ratio (X) | 0.89 | 0.95 | 0.72 | 0.47 | 0.48 |
| Interest Coverage Ratio (X) | 1.79 | 0.40 | 0.73 | 1.06 | 0.27 |
| Interest Coverage Ratio (Post Tax) (X) | 0.77 | -0.50 | -0.08 | 0.67 | 0.38 |
| Enterprise Value (Cr.) | 25036.75 | 10872.67 | 4287.88 | 5607.72 | 6250.83 |
| EV / Net Operating Revenue (X) | 8.31 | 3.89 | 1.62 | 1.74 | 2.31 |
| EV / EBITDA (X) | 55.03 | 89.12 | 19.23 | 17.63 | 90.28 |
| MarketCap / Net Operating Revenue (X) | 7.66 | 3.21 | 0.83 | 1.18 | 1.69 |
| Price / BV (X) | 5.30 | 2.68 | 0.66 | 0.98 | 1.36 |
| Price / Net Operating Revenue (X) | 7.66 | 3.21 | 0.83 | 1.18 | 1.69 |
| EarningsYield | 0.00 | -0.05 | -0.25 | -0.06 | 0.14 |
After reviewing the key financial ratios for Wockhardt Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -3.02. This value is below the healthy minimum of 5. It has increased from -32.05 (Mar 24) to -3.02, marking an increase of 29.03.
- For Diluted EPS (Rs.), as of Mar 25, the value is -3.02. This value is below the healthy minimum of 5. It has increased from -32.05 (Mar 24) to -3.02, marking an increase of 29.03.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.88. This value is within the healthy range. It has increased from -16.17 (Mar 24) to 9.88, marking an increase of 26.05.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 268.70. It has increased from 237.79 (Mar 24) to 268.70, marking an increase of 30.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 268.70. It has increased from 237.79 (Mar 24) to 268.70, marking an increase of 30.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 185.93. It has increased from 181.69 (Mar 24) to 185.93, marking an increase of 4.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 28.09. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 28.09, marking an increase of 20.17.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.69. This value is within the healthy range. It has increased from -6.56 (Mar 24) to 14.69, marking an increase of 21.25.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.98. This value is below the healthy minimum of 0. It has increased from -27.27 (Mar 24) to -0.98, marking an increase of 26.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -3.52. This value is below the healthy minimum of 2. It has increased from -30.65 (Mar 24) to -3.52, marking an increase of 27.13.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -2.90. This value is below the healthy minimum of 2. It has increased from -30.06 (Mar 24) to -2.90, marking an increase of 27.16.
- For PBDIT Margin (%), as of Mar 25, the value is 15.10. This value is within the healthy range. It has increased from 4.36 (Mar 24) to 15.10, marking an increase of 10.74.
- For PBIT Margin (%), as of Mar 25, the value is 7.90. This value is below the healthy minimum of 10. It has increased from -3.60 (Mar 24) to 7.90, marking an increase of 11.50.
- For PBT Margin (%), as of Mar 25, the value is -0.53. This value is below the healthy minimum of 10. It has increased from -15.01 (Mar 24) to -0.53, marking an increase of 14.48.
- For Net Profit Margin (%), as of Mar 25, the value is -1.89. This value is below the healthy minimum of 5. It has increased from -16.86 (Mar 24) to -1.89, marking an increase of 14.97.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.56. This value is below the healthy minimum of 8. It has increased from -16.54 (Mar 24) to -1.56, marking an increase of 14.98.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.07. This value is below the healthy minimum of 15. It has increased from -13.78 (Mar 24) to -1.07, marking an increase of 12.71.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 10. It has increased from -2.07 (Mar 24) to 3.90, marking an increase of 5.97.
- For Return On Assets (%), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has increased from -6.05 (Mar 24) to -0.57, marking an increase of 5.48.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.26 (Mar 24) to 0.27, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.42, marking a decrease of 0.20.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.38. It has increased from 0.36 (Mar 24) to 0.38, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 1.5. It has increased from 0.78 (Mar 24) to 1.26, marking an increase of 0.48.
- For Quick Ratio (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.90, marking an increase of 0.35.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 4. It has decreased from 0.95 (Mar 24) to 0.89, marking a decrease of 0.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.79. This value is below the healthy minimum of 3. It has increased from 0.40 (Mar 24) to 1.79, marking an increase of 1.39.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 3. It has increased from -0.50 (Mar 24) to 0.77, marking an increase of 1.27.
- For Enterprise Value (Cr.), as of Mar 25, the value is 25,036.75. It has increased from 10,872.67 (Mar 24) to 25,036.75, marking an increase of 14,164.08.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.31. This value exceeds the healthy maximum of 3. It has increased from 3.89 (Mar 24) to 8.31, marking an increase of 4.42.
- For EV / EBITDA (X), as of Mar 25, the value is 55.03. This value exceeds the healthy maximum of 15. It has decreased from 89.12 (Mar 24) to 55.03, marking a decrease of 34.09.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.66. This value exceeds the healthy maximum of 3. It has increased from 3.21 (Mar 24) to 7.66, marking an increase of 4.45.
- For Price / BV (X), as of Mar 25, the value is 5.30. This value exceeds the healthy maximum of 3. It has increased from 2.68 (Mar 24) to 5.30, marking an increase of 2.62.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.66. This value exceeds the healthy maximum of 3. It has increased from 3.21 (Mar 24) to 7.66, marking an increase of 4.45.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to 0.00, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Wockhardt Ltd:
- Net Profit Margin: -1.89%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.9% (Industry Average ROCE: 16.63%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.07% (Industry Average ROE: 15.26%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.77
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 56.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.42
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -1.89%
About the Company - Qualitative Analysis
Wockhardt Ltd. is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1402.00 Cr. and Equity Capital is Rs. 81.00 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | D-4, MIDC, Aurangabad Maharashtra 431006 | investorrelations@wockhardt.com http://www.wockhardt.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Habil Khorakiwala | Founder Chairman |
| Dr. Murtaza Khorakiwala | Managing Director |
| Dr. Huzaifa Khorakiwala | Executive Director |
| Ms. Zahabiya Khorakiwala | Non Executive Director |
| Mrs. Tasneem Mehta | Independent Director |
| Mr. Vinesh Kumar Jairath | Independent Director |
| Mr. Akhilesh Gupta | Independent Director |
| Ms. Amelia Fernandes | Independent Director |
| Mr. Ahmad Javed | Independent Director |
FAQ
What is the intrinsic value of Wockhardt Ltd?
Wockhardt Ltd's intrinsic value (as of 26 July 2025) is 40.02 97.62% lower the current market price of 1,678.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 27,257 Cr. market cap, FY2025-2026 high/low of 1,870/833, reserves of 4,272 Cr, and liabilities of 8,100 Cr.
What is the Market Cap of Wockhardt Ltd?
The Market Cap of Wockhardt Ltd is 27,257 Cr..
What is the current Stock Price of Wockhardt Ltd as on 26 July 2025?
The current stock price of Wockhardt Ltd as on 26 July 2025 is 1,678.
What is the High / Low of Wockhardt Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Wockhardt Ltd stocks is ₹1,870/833.
What is the Stock P/E of Wockhardt Ltd?
The Stock P/E of Wockhardt Ltd is .
What is the Book Value of Wockhardt Ltd?
The Book Value of Wockhardt Ltd is 268.
What is the Dividend Yield of Wockhardt Ltd?
The Dividend Yield of Wockhardt Ltd is 0.00 %.
What is the ROCE of Wockhardt Ltd?
The ROCE of Wockhardt Ltd is 3.75 %.
What is the ROE of Wockhardt Ltd?
The ROE of Wockhardt Ltd is 1.22 %.
What is the Face Value of Wockhardt Ltd?
The Face Value of Wockhardt Ltd is 5.00.